WO2007062262A3 - Gelatinous medicament formulation and method of administration - Google Patents
Gelatinous medicament formulation and method of administration Download PDFInfo
- Publication number
- WO2007062262A3 WO2007062262A3 PCT/US2006/045585 US2006045585W WO2007062262A3 WO 2007062262 A3 WO2007062262 A3 WO 2007062262A3 US 2006045585 W US2006045585 W US 2006045585W WO 2007062262 A3 WO2007062262 A3 WO 2007062262A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gelatinous
- administration
- medicament formulation
- gelatin
- active agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Gelatinous compositions are provided which comprise a gelatin or gelatin-like component, water, and one or more active agents, which are advantageously pharmaceuticals, medicaments and/or vitamins and nutrients. The composition of the present invention facilitates the oral ingestion of one or more active agents, such as a therapeutic agent or pharmaceutical, by including the active agent in a gelatinous suspension which can be easily swallowed as a result of its soft, smooth consistency. Methods of making, administering and dispensing are also disclosed.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74007705P | 2005-11-28 | 2005-11-28 | |
| US60/740,077 | 2005-11-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007062262A2 WO2007062262A2 (en) | 2007-05-31 |
| WO2007062262A3 true WO2007062262A3 (en) | 2007-07-12 |
Family
ID=38067984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2006/045585 Ceased WO2007062262A2 (en) | 2005-11-28 | 2006-11-28 | Gelatinous medicament formulation and method of administration |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2007062262A2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6649191B1 (en) * | 1998-04-20 | 2003-11-18 | Glycologic Limited | Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract |
-
2006
- 2006-11-28 WO PCT/US2006/045585 patent/WO2007062262A2/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6649191B1 (en) * | 1998-04-20 | 2003-11-18 | Glycologic Limited | Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007062262A2 (en) | 2007-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2980165C (en) | Liquisoft capsules | |
| US20140335153A1 (en) | Thin film with high load of active ingredient | |
| WO2005046640A3 (en) | Multi-site drug delivery platform | |
| IL179718A0 (en) | Pharmaceutical composition containing irbesartan | |
| WO2004108162A3 (en) | Controlled release pharmaceutical composition | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| EP1365749A4 (en) | PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR USE WITH SOFT GELATINE FORMULATIONS | |
| MX2009004439A (en) | Ibuprofen composition. | |
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| MY160652A (en) | Pharmaceutical composition for oral administration | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| WO2007109684A3 (en) | Dose packaging system for load-dose titration administration of a liquid formulation | |
| NZ594618A (en) | Transdermal pharmaceutical preparations | |
| IL158668A0 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
| WO2007075475A3 (en) | Gastric reflux resistant dosage forms | |
| TW200633978A (en) | 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists | |
| MX2010004556A (en) | Pharmaceutical formulation of clavulanic acid. | |
| EA200700158A1 (en) | MEDICAL FORMS WITH A TABLET NUCLEUS, COVERED WITH THE ENTEROROLEUBLISHING SHELL | |
| WO2003045305A3 (en) | Acetaminophen compositions | |
| WO2003101378A3 (en) | Pharmaceutical formulation in a drug delivery system and process for preparing the same | |
| Haddadzadegan et al. | Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations | |
| WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
| WO2007062262A3 (en) | Gelatinous medicament formulation and method of administration | |
| JP2006316009A (en) | Oral patch and method for producing the same | |
| IL179177A (en) | Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06844604 Country of ref document: EP Kind code of ref document: A2 |